Evolution of Clinical Research: Reflections from DIA Conferences
The evolution of clinical research is clearly visible at the DIA Annual Conference. My first DIA was in 1997 in Montreal, and each year since has offered a snapshot of how the industry continues to change. Viewed over time, DIA tells a story of advancing technologies, shifting operating models, and a growing focus on patients, data, and efficiency.
If you could watch these conferences through time-lapse photography, the progress would be impossible to miss.
The Evolution of Clinical Research Through Industry Milestones
Over the years, DIA has reflected major changes in how clinical trials are designed, managed, and executed. Some of the most notable milestones in the evolution of clinical research include:
-
Rapid growth of the CRO industry through mergers and acquisitions
-
Early data collection using fax and OMR/OCR systems
-
The arrival of EDC, which generated excitement but faced slow adoption due to industry risk aversion
-
Expansion of global Phase III trials
-
Patient recruitment through advertising that helped rescue struggling studies
-
Advances in randomization and drug supply management, reducing waste and costs
-
ePRO proving paper diary data was unreliable
-
Growth in eTMF vendors and risk-based monitoring software
-
Integration of multiple clinical data sources
-
COVID-19 accelerating decentralized trials, remote monitoring, tele-visits, and mobile sites
-
Progress in incorporating EHR/EMR and insurance claims data into clinical research
-
Increased focus on patient diversity and real-world evidence
-
AI dramatically shortening study start-up timelines by automating protocol-driven outputs
Together, these shifts highlight how the evolution of clinical research continues to improve speed, quality, and patient impact.
Observing the Evolution of Clinical Research on the Exhibit Floor
Each year, I walk the entire exhibit hall. This tradition offers a real-time view of where the industry is headed and what challenges sponsors and CROs are trying to solve next.
Beyond technology, the exhibit hall reflects the human side of the evolution of clinical research. Conversations spark new ideas, reconnect colleagues, and uncover opportunities to collaborate. When I speak at the first-time attendee orientation, I encourage everyone to explore the exhibit hall with curiosity and purpose.
Contributing to the Evolution of Clinical Research at DIA
DIA content is created by industry professionals who volunteer their expertise. I strongly encourage colleagues to submit abstracts and contribute to the ongoing evolution of clinical research.
Abstract submissions are due September 14, and details can be found here:
https://www.diaglobal.org/abstract/meeting-details?productID=13251490&productcode=24001CFA
Presenting offers registration discounts, increased visibility, and valuable career growth. More importantly, it allows you to help shape where clinical research goes next.
We hope to see you at DIA 2024 in San Diego.
About GLSA
Global Life Sciences Alliance (GLSA) connects biotechs, pharma, CROs, and clinical research sites with the right experts, advisors, and solutions to accelerate development and reduce risk. With a network of more than 200 trusted partners spanning pre-clinical and clinical research, GLSA offers flexible, cost-effective access to specialized expertise and services that support early-stage biotechs, mid-size pharma, and global pharmaceutical companies.
When you need trusted, global resources to accelerate your research, GLSA helps you scale smarter and move you forward with confidence.
To learn how GLSA can support your organization, connect with Denise McNerney or Chris Matheus for a conversation about your goals and challenges.